α(2B)-Adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems

European Journal of Pharmacology

Volumn 363, Issue 1, 1998, Pages 65-74

  Holmberg, Carina I ^a,b   Kukkonen, Jyrki P ^b,c   Bischoff, Angela ^d   Näsman, Johnny ^c   Courtney, Michael J ^a,b,e   Michel, Martin C ^d   Åkerman, Karl E O ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

(2B) Adrenoceptor; Baculovirus expression system; Ca2+ signaling; Fura 2; NG 108 15; Sf9

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BRIMONIDINE; CYCLIC AMP; NORADRENALIN; OXYMETAZOLINE; PHOSPHOLIPASE C; CALCIUM; LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE; GENE EXPRESSION SYSTEM; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ARMYWORM; CALCIUM SIGNALING; CELL CULTURE; CELL DIVISION; CLASSIFICATION; DOSE RESPONSE; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; MOLECULAR CLONING;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL DIVISION; CELLS, CULTURED; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; RECOMBINANT PROTEINS; SPODOPTERA; TUMOR CELLS, CULTURED;

EID: 0032217064     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00780-8     Document Type: Article

References (53)

1. Aburto T.K., Lajoie C., Morgan K.G. Mechanisms of signal transduction during alpha 2-adrenergic receptor-mediated contraction of vascular smooth muscle. Circ. Res. 72:1993;778-785.
2. 2+. In: Lanier, S.M., Limbird, L. (Eds.), Alpha2-Adrenergic Receptors: Structure, Function and Therapeutic Implications. Harwood Academic Publishers, New York, pp. 85-93.
3. Berridge M.J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
4. Birdsall, N.J., Chan, S.C., Eveleigh, P., Hulme, E.C., Miller, K.W., 1989. The modes of binding of ligands to cardiac muscarinic receptors. Trends Pharmacol. Sci. Suppl., 31-34.
5. + channels in sympathetic neurons by neuropeptides and other ganglionic transmitters. Neuron. 4:1990;379-391.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Butkerait P., Zheng Y., Hallak H., Graham T.E., Miller H.A., Burris K.D., Molinoff P.B., Manning D.R. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270:1995;18691-18699.
8. Bylund D.B., Ray Prenger C. Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther. 251:1989;640-644.
9. Bylund D.B., Ray Prenger C., Murphy T.J. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther. 245:1988;600-607.
10. Campbell M.D., Subramaniam S., Kotlikoff M.I., Williamson J.R., Fluharty S.J. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells. Mol. Pharmacol. 38:1990;282-288.
11. Cotecchia S., Kobilka B.K., Daniel K.W., Nolan R.D., Lapetina E.Y., Caron M.G., Lefkowitz R.J., Regan J.W. Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells. J. Biol. Chem. 265:1990;63-69.
12. Dorn G.W.I., Oswald K.J., McCluskey T.S., Kuhel D.G., Liggett S.B. Alpha2A-Adrenergic receptor stimulated calcium release is transduced by Gi-associated G-betagamma-mediated activation of phospholipase C. Biochemistry. 36:1997;6415-6423.
13. Duzic E., Lanier S.M. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors: III. Coupling of alpha 2-adrenergic receptor subtypes in a cell type-specific manner. J. Biol. Chem. 267:1992;24045-24052.
14. Eason M.G., Jacinto M.T., Liggett S.B. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs. Mol. Pharmacol. 45:1994;696-702.
15. Eason M.G., Kurose H., Holt B.D., Raymond J.R., Liggett S.B. Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J. Biol. Chem. 267:1992;15795-15801.
16. Enkvist M.O., Hämäläinen H., Jansson C.C., Kukkonen J.P., Hautala R., Courtney M.J., Åkerman K.E. Coupling of astroglial alpha 2-adrenoreceptors to second messenger pathways. J. Neurochem. 66:1996;2394-2401.
17. 2+ in cultured porcine aortic smooth muscle cells. J. Cardiovasc. Pharmacol. 22:1993;97-102.
18. Feng G., Hannan F., Reale V., Hon Y.Y., Kousky C.T., Evans P.D., Hall L.M. Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster. J. Neurosci. 16:1996;3925-3933.
19. Feth F., Rascher W., Michel M.C. Neuropeptide Y (NPY) receptors in HEL cells: comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist. Br. J. Pharmacol. 105:1992;71-76.
20. Fraser C.M., Arakawa S., McCombie W.R., Venter J.C. Cloning, sequence analysis, and permanent expression of a human alpha 2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J. Biol. Chem. 264:1989;11754-11761.
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
22. 2+ mobilization by the LH receptor expressed in Xenopus oocytes independent of 3′,5′-cyclic adenosine monophosphate formation: evidence for parallel activation of two signaling pathways. Mol. Endocrinol. 6:1992;272-278.
23. Hieble J.P., Bondinell W.E., Ruffolo R.J. Alpha- and beta-adrenoceptors: from the gene to the clinic: 1. Molecular biology and adrenoceptor subclassification. J. Med. Chem. 38:1995;3415-3444.
24. Holz G.G.t., Rane S.G., Dunlap K. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature. 319:1986;670-672.
25. Jansson C.C., Karp M., Oker-Blom C., Näsman J., Savola J.M., Åkerman K.E. Two human alpha 2-adrenoceptor subtypes alpha 2A-C10 and alpha 2B-C2 expressed in Sf9 cells couple to transduction pathway resulting in opposite effects on cAMP production. Eur. J. Pharmacol. 290:1995;75-83.
26. Jansson C.C., Marjamäki A., Luomala K., Savola J.M., Scheinin M., Åkerman K.E. Coupling of human alpha 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells. Eur. J. Pharmacol. 266:1994;165-174.
27. Kagaya A., Mikuni M., Yamamoto H., Muraoka S., Yamawaki S., Takahashi K. Heterologous supersensitization between serotonin2 and alpha 2-adrenergic receptor-mediated intracellular calcium mobilization in human platelets. J. Neural Transm. Gen. Sect. 88:1992;25-36.
28. Karp M., Akerman K., Lindqvist C., Kuusisto A., Saviranta P., Oker Blom C. A sensitive model system for in vivo monitoring of baculovirus gene expression in single infected insect cells. Biotechnology NY. 10:1992;565-569.
29. Kukkonen J.P., Näsman J., Ojala P., Oker-Blom C., Åkerman K.E.O. Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system. J. Pharmacol. Exp. Ther. 279:1996;593-601.
30. Lee S.B., Shin S.H., Hepler J.R., Gilman A.G., Rhee S.G. Activation of phospholipase C-beta 2 mutants by G protein alpha q and beta gamma subunits. J. Biol. Chem. 268:1993;25952-25957.
31. Lepretre N., Mironneau J. Alpha 2-adrenoceptors activate dihydropyridine-sensitive calcium channels via Gi-proteins and protein kinase C in rat portal vein myocytes. Pflügers Arch. 429:1994;253-261.
32. Limbird L.E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 2:1988;2686-2695.
33. McClue S.J., Milligan G. The alpha 2B adrenergic receptor of undifferentiated neuroblastoma×glioma hybrid NG108-15 cells, interacts directly with the guanine nucleotide binding protein, Gi2. FEBS Lett. 269:1990;430-434.
34. 2+ in human erythroleukemia cells. J. Biol. Chem. 264:1989;4091-4986.
35. 3H ]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site Mol. Pharmacol. 35:1989;324-330.
36. Musgrave I.F., Seifert R. Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium. Biochem. Pharmacol. 49:1995;187-196.
37. Ng G.Y., George S.R., Zastawny R.L., Caron M., Bouvier M., Dennis M., BF O.D. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry. 32:1993;11727-11733.
38. Oker-Blom C., Jansson C., Karp M., Lindqvist C., Savola J.M., Vlak J., Åkerman K. Functional analysis of the human alpha 2C-C4 adrenergic receptor in insect cells expressed by a luciferase-based baculovirus vector. Biochim. Biophys. Acta. 1176:1993;269-275.
39. Palmer S., Hawkins P.T., Michell R.H., Kirk C.J. The labelling of polyphosphoinositides with [32P]Pi and the accumulation of inositol phosphates in vasopressin-stimulated hepatocytes. Biochem. J. 238:1986;491-499.
40. Pepperl D.J., Regan J.W. Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. Mol. Pharmacol. 44:1993;802-809.
41. Quehenberger O., Prossnitz E.R., Cochrane C.G., Ye R.D. Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor. J. Biol. Chem. 267:1992;19757-19760.
42. Regan, J.W., Cotecchia, S., 1992. The alpha-adrenergic receptors: new subtypes, pharmacology, and coupling mechanisms. In: Brann, M.R. (Ed.), Molecular Biology of G-protein-coupled Receptors. Birkhäuser, Basel, pp. 76-112.
43. Ruffolo R.R. Jr., Nichols A.J., Stadel J.M., Hieble J.P. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes. Annu. Rev. Pharmacol. Toxicol. 32:1993;243-279.
44. Salm A.K., McCarthy K.D. Norepinephrine-evoked calcium transients in cultured cerebral type 1 astroglia. Glia. 3:1990;529-538.
45. Smrcka A.V., Sternweis P.C. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J. Biol. Chem. 268:1993;9667-9674.
46. Stickle D., Barber R. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Mol. Pharmacol. 36:1989;437-445.
47. Summers, M.D., Smith, G.E., 1987. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Texas Agriculture Experiment Station, TX.
48. Waldo G.L., Boyer J.L., Morris A.J., Harden T.K. Purification of an AlF4- and G-protein beta gamma-subunit-regulated phospholipase C-activating protein. J. Biol. Chem. 266:1991;14217-14225.
49. Whaley B.S., Yuan N., Birnbaumer L., Clark R.B., Barber R. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol. Pharmacol. 45:1994;481-489.
50. Wilson A.L., Seibert K., Brandon S., Cragoe E.J. Jr., Limbird L.E. Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtype. Mol. Pharmacol. 39:1991;481-486.
51. Volpe P., Alderson-Lang B.H. Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release: II. Effect of cAMP-dependent protein kinase. Am. J. Physiol. 258:1990;C1086-1091.
52. Wu D., Katz A., Simon M.I. Activation of phospholipase C beta 2 by the alpha and beta gamma subunits of trimeric GTP-binding protein. Proc. Natl. Acad. Sci. USA. 90:1993;5297-5301.
53. Yakel J.L., Warren R.A., Reppert S.M., North R.A. Functional expression of adenosine A2b receptor in Xenopus oocytes. Mol. Pharmacol. 43:1993;277-280.